Phorbiplatin, a new “on-site” activated anti-tumor prodrug that effectively kills cancer cells minimizing damage to normal tissues.
A new anti-cancer chemical compound was found capable of reducing tumour size and weight by up to two-thirds in laboratory tests done by researchers from